Description

Takhzyro is a medication used for the prophylaxis of attacks of hereditary angioedema in adults and adolescents. It works by inhibiting the activation of the complement system, which is involved in the inflammatory response.

Interpreter Notes

Interpreters should be aware that 'Takhzyro' may sometimes be referred to by its generic name, lanadelumab, in clinical discussions. It is important to maintain a formal register and avoid colloquial terms when interpreting. Ensure clarity in communication to prevent confusion with other medications that treat similar conditions.

Example Sentences

EN: The doctor prescribed Takhzyro to help manage the patient's hereditary angioedema.

ES: El médico recetó Takhzyro para ayudar a controlar el angioedema hereditario del paciente.

Common Interpreter Mistakes

Confusing Takhzyro with other angioedema treatments; mispronouncing Takhzyro as if it were a Spanish word; using informal language when discussing the medication.